BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 36661350)

  • 1. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
    Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
    J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of DCE-MRI and NME-DWI via Deep Neural Network for Predicting Breast Cancer Molecular Subtypes.
    Ba ZC; Zhang HX; Liu AY; Zhou XX; Liu L; Wang XY; Nanding A; Sang XQ; Kuai ZX
    Clin Breast Cancer; 2024 Mar; ():. PubMed ID: 38555225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MR Imaging Radiomics Signatures for Assessing the Recurrence Risk of ER+/HER2- Breast Cancer Quantified With 21-Gene Recurrence Score.
    Chen Y; Tang W; Liu W; Li R; Wang Q; Shen X; Gong J; Gu Y; Peng W
    J Magn Reson Imaging; 2023 Aug; 58(2):444-453. PubMed ID: 36440706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra- and Peritumoral Based Radiomics for Assessment of Lymphovascular Invasion in Invasive Breast Cancer.
    Jiang W; Meng R; Cheng Y; Wang H; Han T; Qu N; Yu T; Hou Y; Xu S
    J Magn Reson Imaging; 2024 Feb; 59(2):613-625. PubMed ID: 37199241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Channel-Dimensional Feature-Reconstructed Deep Learning Model for Predicting Breast Cancer Molecular Subtypes on Overall b-Value Diffusion-Weighted MRI.
    Zhou XX; Zhang L; Cui QX; Li H; Sang XQ; Zhang HX; Zhu YM; Kuai ZX
    J Magn Reson Imaging; 2024 Apr; 59(4):1425-1435. PubMed ID: 37403945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
    Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
    J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics.
    Zheng S; Yang Z; Du G; Zhang Y; Jiang C; Xu T; Li B; Wang D; Qiu Y; Lin D; Zhang X; Shen J
    Eur Radiol; 2024 Feb; ():. PubMed ID: 38363315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between dynamic contrast-enhanced MRI characteristics and apparent diffusion coefficient with Ki-67-positive expression in non-mass enhancement of breast cancer.
    Nie T; Feng M; Yang K; Guo X; Yuan Z; Zhang Z; Yan G
    Sci Rep; 2023 Dec; 13(1):21451. PubMed ID: 38052920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasts Between Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MR in Diagnosing Malignancies of Breast Nonmass Enhancement Lesions Based on Morphologic Assessment.
    Li Y; Chen J; Yang Z; Fan C; Qin Y; Tang C; Yin T; Ai T; Xia L
    J Magn Reson Imaging; 2023 Sep; 58(3):963-974. PubMed ID: 36738118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Tumor-Infiltrating Lymphocytes in Breast Cancer Using Preoperative MRI-Based Radiomics.
    Bian T; Wu Z; Lin Q; Mao Y; Wang H; Chen J; Chen Q; Fu G; Cui C; Su X
    J Magn Reson Imaging; 2022 Mar; 55(3):772-784. PubMed ID: 34453461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral and Peritumoral Analysis of Mammography, Tomosynthesis, and Multiparametric MRI for Predicting Ki-67 Level in Breast Cancer: a Radiomics-Based Study.
    Jiang T; Song J; Wang X; Niu S; Zhao N; Dong Y; Wang X; Luo Y; Jiang X
    Mol Imaging Biol; 2022 Aug; 24(4):550-559. PubMed ID: 34904187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI.
    Niu S; Jiang W; Zhao N; Jiang T; Dong Y; Luo Y; Yu T; Jiang X
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):97-106. PubMed ID: 34623517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment Multiparametric MRI-Based Radiomics Analysis for the Diagnosis of Breast Phyllodes Tumors.
    Ma X; Gong J; Hu F; Tang W; Gu Y; Peng W
    J Magn Reson Imaging; 2023 Feb; 57(2):633-645. PubMed ID: 35657093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
    Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
    J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of radiomics models for tumour-infiltrating lymphocyte (TIL) prediction in breast cancer: the role of the dynamic contrast-enhanced (DCE) MRI phase.
    Tang WJ; Kong QC; Cheng ZX; Liang YS; Jin Z; Chen LX; Hu WK; Liang YY; Wei XH; Guo Y; Jiang XQ
    Eur Radiol; 2022 Feb; 32(2):864-875. PubMed ID: 34430998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Upstaging in Ductal Carcinoma In Situ Using Preoperative MRI-Based Radiomics.
    Hong M; Fan S; Yu Z; Gao C; Fang Z; Du L; Wang S; Chen X; Xu M; Zhou C
    J Magn Reson Imaging; 2023 Aug; 58(2):454-463. PubMed ID: 36440711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Using CNN Based on Multiparametric MRI.
    Wang Z; Sun H; Li J; Chen J; Meng F; Li H; Han L; Zhou S; Yu T
    J Magn Reson Imaging; 2022 Sep; 56(3):700-709. PubMed ID: 35108415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.